This Week in Science

In Science this week, a team from Memorial Sloan-Kettering Cancer Center reports on its discovery of genetic mutations that improve the clinical response to the cancer drug everolimus. The researchers sequenced the genome of a metastatic bladder cancer patient who had shown a complete and long-lasting response to the drug, which targets the signaling protein mTORC1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Up All Night

This Week in PNAS

This Week in Nature

This Week in PNAS

This Week in Cell

This Week in PLOS

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.

In a column at Nature, researcher Fyodor Kondrashov worries about the influence of politics on Russian science.

The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.

The NIH has issued a preliminary guidance for newborn dried blood spot research.